Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating expenses:
Research and development expenses	$ 19,025,832	$ 22,565,524
General and administrative expenses	12,518,127	13,755,671
Total operating expenses	31,543,959	36,321,195
Loss from operations	(31,543,959)	(36,321,195)
Interest income (expense), net
Interest income	1,217,241	2,514,816
Interest expense	(5,338,607)	(4,673,174)
Interest income (expenses), net	(4,121,366)	(2,158,358)
Loss before income taxes	(35,665,325)	(38,479,553)
Benefit for income taxes	1,169,820	869,169
Net loss	(34,495,505)	(37,610,384)
Comprehensive loss	$ (34,495,505)	$ (37,610,384)
Per share information:
Net loss per share, basic (in dollars per share)	$ (0.74)	$ (1.03)
Net loss per share, diluted (in dollars per share)	$ (0.74)	$ (1.03)
Weighted average common shares outstanding, basic (in shares)	46,384,280	36,452,707
Weighted average common shares outstanding, diluted (in shares)	46,384,280	36,452,707